Slate Medicines Appoints Mark W. Hahn to Board of Directors
By Daniella Parra Slate Medicines, a private biotech company developing new treatments for migraine and...

By Daniella Parra Slate Medicines, a private biotech company developing new treatments for migraine and...
By Daniella Parra Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) said its Enhanced Brain Delivery (EBD) bispecific antibodies...
-HyProMag USA, a JV with CoTec Holdings Corp. (OTC: CTHCF), is building a U.S. rare-earth...
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on at...
By Exec Edge Editorial Staff AZA Law Firm opened its Dallas office at the Trammell...
By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued...
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it expects BiTAC molecules to be...
By Karen Roman CareDx, Inc. (Nasdaq: CDNA) said it completed the acquisition of Naveris, which...
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it started cell line development for...
By Karen Roman SkylineDx said the FDA granted Breakthrough Device Designation to Merlin CP-GEP, the...